Ghasak Mahmood
Endocrinology, Diabetes & Metabolism · Laguna Hills, CANPI 1215116116
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $13,125 of the $19,419 with a category attached, or 67.6%. Lilly USA, LLC accounts for 86.5% of it on its own, with 11 other manufacturers making up the rest. 2023 is the largest year on record at $16,976, more than ten times the $520 reported in 2019.
Across 237 payments — averaging $81.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$17K
- Novo Nordisk$1K
- Dexcom, Inc.$530
- Insulet Corporation$270
- Abbott$235
- Medtronic$124
- plus $198 from 6 others
What the payments were for
- Speaking & faculty fees$13,12568%
- Travel & lodging$3,00215%
- Food & beverage$3,06616%
- Education$2261%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 46 | $16,792 |
| Novo Nordisk | 107 | $1,271 |
| Dexcom, Inc. | 46 | $530 |
| Insulet Corporation | 18 | $270 |
| Abbott | 7 | $235 |
| Medtronic(2 entities) | 5 | $124 |
| Amgen | 2 | $69 |
| Novartis | 2 | $45 |
| Bigfoot Biomedical Inc | 1 | $35 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
| IBSA Pharma Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MOUNJARO$13,936
- FreeStyle Libre Pro$125
How this compares
$19,419 in reported general payments places this provider in the 85th percentile of 952 endocrinology, diabetes & metabolism providers in California.
See all endocrinology, diabetes & metabolism providers in California →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humalog Kwikpen U-100Insulin Lispro | 11 | $2,925 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $1,701 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 19 | $1,607 |
| Levothyroxine Sodium | 22 | $419 |
| Metformin Hcl | 17 | $228 |
Paid to pharmacies, not to this prescriber.
Other endocrinology, diabetes & metabolism in Laguna Hills
- Alan MarcusLaguna Hills$119K
- Juan FriasSan Diego$1.4M
- Joselito CabaccanSan Jose$1.4M
- Daniel NadeauNewport Beach$1.2M
- Yehuda HandelsmanTarzana$1M
- Helen BaronRancho Mirage$958K
- Ken FujiokaSan Diego$747K
- Minou TranPico Rivera$663K
- James ChuMonterey$639K
- Anthony HeaneyLos Angeles$588K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.